Multicellular living organisms and unmodified parts thereof and – Method of using a transgenic nonhuman animal in an in vivo...
Reexamination Certificate
2011-04-19
2011-04-19
Falk, Anne-Marie (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Method of using a transgenic nonhuman animal in an in vivo...
C800S013000, C800S014000, C800S018000, C424S009100
Reexamination Certificate
active
07928284
ABSTRACT:
Methods for testing candidate drugs for treatment of age-related macular degeneration are provided. Ccl2-deficient, and Ccr2-deficient mice are used to determine the effect of candidate drugs and treatments on development of age-related macular degeneration. Also provided is a Ccl2-deficient, Ccr2-deficient dual knockout mouse, which is a useful animal model for age-related macular degeneration.
REFERENCES:
Ambati, J. et al. “An animal model of age-related macular degeneration in senescent macrophage recruitment impaired mice.” Association for Research in Vision Opthalmology Annual Meeting Abstract Search and Program Planner, 2003.
Grossniklaus, H. et al. “Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.” Molecular Vision, 2002, vol. 8, pp. 119-126.
Kuziel, W. et al. “Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.” Proceedings of the National Academy of Sciences USA, Oct. 1997, vol. 94, pp. 12053-12058.
Lu, B. et al. “Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1-deficient Mice.” Journal of Experimental Medicine, Feb. 1998, vol. 187, pp. 601-608.
Raisler, B. et al. “Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.” PNAS, Jun. 2002, vol. 99, pp. 8909- 8914.
Acland, Gregory, M., et al. “Gene therapy restores vision in canine model of childhood blindness.” Nature Genetics, vol. 28, May 2001, pp. 92-95.
Elner, Victor, M., et al. “Cell-Associated Human Retinal Pigment Epithelium Interleukin-8 and Monocyte Chemotactic Protein-1: Immunochemical and In-situ Hybridization Analyses.” Experimental Eye Research, Dec. 1997, vol. 65, No. 6, pp. 781-789.
Doetschman, T. (1999) Interpretation of phenotype in genetically engineered mice. Laboratory Animal Science 49(2): 137-143.
Donehower et al. (1995) Effects of genetic background on tumorigenesis in p53-deficient mice. Molecular Carnicogenesis 14: 16-22.
Jacks et al. (1992) Effects of an Rb mutation in the mouse. Nature 359: 295-300.
Jaenisch et al. (1988) Transgenic Animals. Science 240: 1468-1474.
Kuehn et al. (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326: 295-298.
Petridou et al. (2003) Heterogeneous inducible mammary-specific expression of JAB/SOCS1 in lactating transgenic mice is associated with no obvious phenotype, even at the cellular level. Transgenic Research 12: 693-706.
Sigmund, CD (2000) Viewpoint: Are studies in genetically altered mice out of control? Arterioscler. Thromb. Vasc. Biol. 20: 1425-4129.
C.B. Moens et al., “Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myclocus,” Development 119, 485-499 (1993).
Falk Anne-Marie
McDermott Will & Emery LLP
University of Kentucky Research Foundation
LandOfFree
Methods and animal model for analyzing age-related macular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and animal model for analyzing age-related macular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and animal model for analyzing age-related macular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660482